Ocumension Therapeutics Forecast, price target & analysts
Ocumension Therapeutics Target price 2026 - Analyst rating & recommendation
Ocumension Therapeutics Classifications & Recommendation
Ocumension Therapeutics Price Target
| Target Price | HK$8.36 |
| Price | HK$5.22 |
| Potential |
60.23%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Ocumension Therapeutics 2027 .
The average Ocumension Therapeutics target price is HK$8.36.
This is
60.23%
register free of charge
HK$8.90
70.57%
register free of charge
HK$8.00
53.24%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Ocumension Therapeutics to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ocumension Therapeutics stock has an average upside potential 2027 of
60.23%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 0.94 | 1.30 |
| 92.75% | 37.63% | |
| EBITDA Margin | -19.15% | 12.06% |
| 71.32% | 162.96% | |
| Net Margin | -19.75% | -0.75% |
| 69.29% | 96.20% |
4 Analysts have issued a sales forecast Ocumension Therapeutics 2026 . The average Ocumension Therapeutics sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Ocumension Therapeutics EBITDA forecast 2026. The average Ocumension Therapeutics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Ocumension Therapeutics Analysts have issued a net profit forecast 2026. The average Ocumension Therapeutics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | -0.23 | -0.01 |
| 50.00% | 95.65% | |
| P/E | negative | |
| EV/Sales | 2.99 |
4 Analysts have issued a Ocumension Therapeutics forecast for earnings per share. The average Ocumension Therapeutics EPS is
This results in the following potential growth metrics and future valuations:
Ocumension Therapeutics...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
